WMCC Earns Reaccreditation from ACHC
Kalamazoo, MI – West Michigan Cancer Center Radiation & Surgical Specialties (WMCC) is proud to announce it has once again earned reaccreditation from the Accreditation Commission for Health Care (ACHC) for its gynecologic, radiation, and surgical oncology services.
Reaccreditation by ACHC recognizes WMCC’s ongoing commitment to delivering exceptional cancer care while maintaining the highest standards of safety, quality, and patient outcomes.
“Achieving reaccreditation reflects the dedication of our entire team,” said Bridget VandenBussche, MHA, CPHRM, and executive director of WMCC. “Every physician, nurse, therapist, and staff member plays a vital role in ensuring that our patients receive compassionate, evidence-based care in a safe and supportive environment. This recognition affirms that commitment.”
WMCC Division Chief of Radiation Oncology, Mazen Mislmani, MD, explained that ACHC reaffirmation underscores the discipline, consistency, and commitment our patients count on every day. “Reaccreditation isn’t a formality for us; it’s a rigorous assessment of whether our clinical standards truly align with best practices. Our team embraces that level of accountability,” said Dr. Mislmani.
WMCC Quality and Risk Manager Blair Pease added that reaccreditation is more than meeting a set of standards every few years—it reflects WMCC’s daily commitment to patients. “This success is a true team effort, and it assures our community that we hold ourselves accountable to the highest quality and safety benchmarks in healthcare,” said Pease.
ACHC, a nonprofit organization established in 1986, is recognized as a symbol of quality and excellence in healthcare. WMCC remains committed to continuous improvement and adherence to ACHC accreditation standards—ensuring patients receive safe, effective, and compassionate cancer care.
For more information, visit wmcc.org or contact marketing@wmcc.org or 269-384-8624.
About West Michigan Cancer Center
West Michigan Cancer Center (WMCC) has been a regional leader in cancer care since its founding. As a collaborative partnership among area health systems, WMCC provides integrated, patient-centered oncology services that bring world-class expertise close to home.
Founded in 1994, as a not-for-profit collaboration between Beacon Health Kalamazoo (formerly Ascension Borgess) and Bronson Healthcare, WMCC has been a light of hope for cancer patients. From its 55,000 square-foot facility at 200 North Park Street in downtown Kalamazoo, WMCC offers comprehensive, multidisciplinary, and integrative cancer treatment. Annually, WMCC welcomes around 2,500 new patients seeking its expert guidance and care.
An executive director, board of directors and senior medical staff comprise the leadership team. Service offerings include radiation oncology, gynecologic oncology, and surgical oncology. A licensed medical social worker and a registered dietitian offer assistance with basic needs, transportation, lodging, coping skills, nutrition counseling, resource navigation and more.
WMCC proudly participates in the Cancer Research Consortium of West Michigan (CRCWM), an affiliate of the National Cancer Institute Clinical Oncology Research Program (NCORP). The center holds accreditations from the American College of Radiation Oncology (ACRO), the Accreditation Commission for Health Care (ACHC), the National Pancreas Foundation and the Michigan Radiation Oncology Quality Consortium (MROQC), reflecting its unwavering commitment to exceptional patient care and clinical excellence.